Working… Menu

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04123574
Recruitment Status : Recruiting
First Posted : October 11, 2019
Last Update Posted : November 14, 2019
IQVIA Biotech
Information provided by (Responsible Party):
BioXcel Therapeutics Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 31, 2020
Estimated Study Completion Date : November 30, 2020